ArticleJournal of evidence-based medicine2020
SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.
Article in Journal of evidence-based medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.Frontiers in medicine · 2022Pooled it
- Current status of coronavirus disease 2019 vaccine research based on bibliometric analysis.Human vaccines & immunotherapeutics · 2022Trial
- Top 100 cited research on COVID-19 vaccines: A bibliometric analysis and evidence mapping.Human vaccines & immunotherapeutics · 2024Review
- Insights into structural vaccinology harnessed for universal coronavirus vaccine development.Clinical and experimental vaccine research · 2024Review
- Advancing molecular modeling and reverse vaccinology in broad-spectrum yellow fever virus vaccine development.Scientific reports · 2024Article
- SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode.Communications biology · 2023Article
- Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools.Viruses · 2023Review
- Tracking trends in COVID-19 vaccines based on 47 different vaccines: A bibliometric review.Human vaccines & immunotherapeutics · 2023Review
- SARS-CoV-2 Spike Protein Interaction Space.International journal of molecular sciences · 2023Article
- Safety of mRNA COVID-19 vaccinations in patients with allergic diseases.Public health in practice (Oxford, England) · 2023Article
- A critical appraisal of neurological evidence on paediatric COVID-19 patients. A systematic literature review.Heliyon · 2023Review
- Exploiting reverse vaccinology approach for the design of a multiepitope subunit vaccine against the major SARS-CoV-2 variants.Computational biology and chemistry · 2022Article
- Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in medical personnel.Postepy dermatologii i alergologii · 2022Article
- COVID-19 pandemic evolution in the Brazilian Indigenous population.Journal of racial and ethnic health disparities · 2022Article
- A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.Frontiers in immunology · 2022Article
- Molnupiravir and Its Antiviral Activity Against COVID-19.Frontiers in immunology · 2022Review
- Characterization of the expressed RNA variants from young patients with critical and non-critical SARS-CoV-2 infection.The Egyptian journal of medical human genetics · 2022Article
- Investigating expressed RNA variants that are related to disease severity in SARS-CoV-2-infected patients with mild-to-severe disease.The Egyptian journal of medical human genetics · 2022Article
- In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2.Journal of clinical medicine · 2021Article
- Emerging role of air pollution and meteorological parameters in COVID-19.Journal of evidence-based medicine · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.